First reported 14 hours ago -
Updated 14 hours ago -
In a recent unanimous U.S. Supreme Court ruling, the court opened the door for private parties, including competitors, to bring false advertising and misrepresentation
claims under the Lanham Act even if the product labels comply with all FDA regulations. ...
[Published JD Supra - 14 hours ago]